bismuth subcarbonate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 5626 | 5892-10-4 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
None
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Dogs | Bacterial enteritis associated diarrhea | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Amforol Suspension | Zoetis Inc. | 3 |
| Amforol Veterinary Oral Tablets | Zoetis Inc. | 3 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| CHEBI:31291 | CHEBI |
| CHEMBL1727605 | ChEMBL_ID |
| C028508 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB11281 | DRUGBANK_ID |
| 001157 | NDDF |
| 001907 | NDDF |
| 4019038 | VANDF |
| C0053789 | UMLSCUI |
| 17212003 | SNOMEDCT_US |
| 422213004 | SNOMEDCT_US |
| D01757 | KEGG_DRUG |
| 16683095 | PUBCHEM_CID |
| 19475 | RXNORM |
| 4287 | MMSL |
| NOCODE | MMSL |
| M41L2IN55T | UNII |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Estomarol | HUMAN OTC DRUG LABEL | 5 | 57465-100 | POWDER | 0.21 g | ORAL | OTC monograph final | 10 sections |
| Sha-lem | HUMAN OTC DRUG LABEL | 5 | 59862-100 | OINTMENT | 1.89 g | TOPICAL | unapproved drug other | 10 sections |